This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Jefferies Sticks to Their Buy Rating for EssilorLuxottica SA (0OMK)
In a report released today, Julien Dormois from Jefferies maintained a Buy rating on EssilorLuxottica SA, with a price target of €325.00.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Dormois is an analyst with an average return of -7.6% and a 33.75% success rate. Dormois covers the Healthcare sector, focusing on stocks such as EssilorLuxottica SA, Siemens Healthineers AG, and Koninklijke Philips N.V..
In addition to Jefferies, EssilorLuxottica SA also received a Buy from Barclays’s Hassan Al-Wakeel in a report issued on February 12. However, on the same day, Bernstein maintained a Hold rating on EssilorLuxottica SA (LSE: 0OMK).
0OMK market cap is currently €119.4B and has a P/E ratio of 51.22.
Read More on GB:0OMK:
Disclaimer & DisclosureReport an Issue
- EssilorLuxottica price target lowered to EUR 335 from EUR 345 at JPMorgan
- EssilorLuxottica reports Q4 revenue ex-FX up 18.4% to EUR 7.6B
- EssilorLuxottica price target lowered to EUR 315 from EUR 339 at Citi
- EssilorLuxottica: Rich Valuation and Strategic Tech Pivot Justify Market-Perform (Hold) Rating
- EssilorLuxottica price target lowered to EUR 350 from EUR 360 at Barclays
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
